143 related articles for article (PubMed ID: 29526777)
1. Comparative proteomic analysis of chief and oxyphil cell nodules in refractory uremic hyperparathyroidism by iTRAQ coupled LC-MS/MS.
Li S; Mao J; Wang M; Zhang M; Ni L; Tao Y; Huang B; Chen J
J Proteomics; 2018 May; 179():42-52. PubMed ID: 29526777
[TBL] [Abstract][Full Text] [Related]
2. Integrated transcriptomic and proteomic analyses for the characterization of parathyroid oxyphil cells in uremic patients.
Mao J; You H; Wang M; Ni L; Zhang Q; Zhang M; Chen J
Amino Acids; 2022 May; 54(5):749-763. PubMed ID: 35348903
[TBL] [Abstract][Full Text] [Related]
3. Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism?
Lomonte C; Vernaglione L; Chimienti D; Bruno A; Cocola S; Teutonico A; Cazzato F; Basile C
Clin J Am Soc Nephrol; 2008 May; 3(3):794-9. PubMed ID: 18322048
[TBL] [Abstract][Full Text] [Related]
4. Single-cell RNA sequencing reveals transdifferentiation of parathyroid chief cells into oxyphil cells in patients with uremic secondary hyperparathyroidism.
Mao J; You H; Wang M; Ba Y; Qian J; Cheng P; Lu C; Chen J
Kidney Int; 2024 Mar; 105(3):562-581. PubMed ID: 38142040
[TBL] [Abstract][Full Text] [Related]
5. Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.
Ritter C; Miller B; Coyne DW; Gupta D; Zheng S; Brown AJ; Slatopolsky E
Kidney Int; 2017 Nov; 92(5):1217-1222. PubMed ID: 28750928
[TBL] [Abstract][Full Text] [Related]
6. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
Mao J; Wang M; Ni L; Gong W; Jiang X; Zhang Q; Zhang M; Wen D; Chen J
Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33912936
[TBL] [Abstract][Full Text] [Related]
7. Differential gene expression by oxyphil and chief cells of human parathyroid glands.
Ritter CS; Haughey BH; Miller B; Brown AJ
J Clin Endocrinol Metab; 2012 Aug; 97(8):E1499-505. PubMed ID: 22585091
[TBL] [Abstract][Full Text] [Related]
8. Relationship between parathyroid oxyphil cell proportion and clinical characteristics of patients with chronic kidney disease.
Ding Y; Zou Q; Jin Y; Zhou J; Wang H
Int Urol Nephrol; 2020 Jan; 52(1):155-159. PubMed ID: 31686279
[TBL] [Abstract][Full Text] [Related]
9. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
Lomonte C; Martino R; Selvaggiolo M; Bona RM; Cazzato F; Milano R; Chiarulli G; Basile C
J Nephrol; 2003; 16(5):716-20. PubMed ID: 14733419
[TBL] [Abstract][Full Text] [Related]
10. The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD.
Lu CL; Yeih DF; Hou YC; Jow GM; Li ZY; Liu WC; Zheng CM; Lin YF; Shyu JF; Chen R; Huang CY; Lu KC
Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513912
[TBL] [Abstract][Full Text] [Related]
11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
12. Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
Slatopolsky E; Finch JL; Brown AJ; Ritter CS; Mizobuchi M; Plum LA; Clagett-Dame M; Sicinski RR; DeLuca HF
J Bone Miner Res; 2007 May; 22(5):686-94. PubMed ID: 17444814
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
Wang X; Sun B; Zhou F; Hu J; Yu X; Peng T
Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
[TBL] [Abstract][Full Text] [Related]
14. Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.
Ritter CS; Zhang S; Delmez J; Finch JL; Slatopolsky E
Kidney Int; 2015 Jun; 87(6):1141-52. PubMed ID: 25692955
[TBL] [Abstract][Full Text] [Related]
15. The oxyphil cell in abnormal parathyroid glands. A study of 114 cases.
Allen TB; Thorburn KM
Arch Pathol Lab Med; 1981 Aug; 105(8):421-7. PubMed ID: 6894851
[TBL] [Abstract][Full Text] [Related]
16. Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride.
Sumida K; Nakamura M; Ubara Y; Marui Y; Tanaka K; Takaichi K; Tomikawa S; Inoshita N; Ohashi K
J Clin Pathol; 2011 Sep; 64(9):756-60. PubMed ID: 21565858
[TBL] [Abstract][Full Text] [Related]
17. Differential influence of vitamin D analogs on left ventricular mass index in maintenance hemodialysis patients.
Sezer S; Tutal E; Bal Z; Uyar ME; Bal U; Cakir U; Acar NO; Haberal M
Int J Artif Organs; 2014 Feb; 37(2):118-25. PubMed ID: 24619898
[TBL] [Abstract][Full Text] [Related]
18. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
Kidney Blood Press Res; 2013; 37(1):84-94. PubMed ID: 23552627
[TBL] [Abstract][Full Text] [Related]
19. The function of the parathyroid oxyphil cells in uremia: still a mystery?
Basile C; Lomonte C
Kidney Int; 2017 Nov; 92(5):1046-1048. PubMed ID: 29055426
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.
Tokumoto M; Taniguchi M; Matsuo D; Tsuruya K; Hirakata H; Iida M
Ther Apher Dial; 2005 Aug; 9 Suppl 1():S27-34. PubMed ID: 16109139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
